DAWN JEANNERAT: Open Payments
NPI 1922471556 · DU BOIS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,148 in 21 payments from 9 companies in 2025. Trend: 2023 $44,159 · 2024 $18,236 · 2025 $2,148
Speaker / faculty: $1,493Food & beverage: $656
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 3 | $1,493 |
| AstraZeneca Pharmaceuticals LP | 9 | $399 |
| Verona Pharma, Inc. | 1 | $93 |
| Novo Nordisk Inc | 2 | $42 |
| Ambu Inc. | 1 | $35 |
| GlaxoSmithKline, LLC. | 2 | $30 |
| Merck Sharp & Dohme LLC | 1 | $28 |
| Electromed, Inc. | 1 | $27 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $2 |
Products named: DUPIXENT, AIRSUPRA, Ohtuvayre, TEZSPIRE, Wegovy, TRELEGY ELLIPTA, WINREVAIR, SMARTVEST.
Industry payments across PA — which companies pay providers there.
